ArrowMark Colorado Holdings’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-986,137	Closed	-$24.1M	–	358
2017 Q4	$24.1M	Buy	986,137 +220,961	+29%	+$4.25M	0.24%	105
2017 Q3	$14.1M	Buy	765,176 +153,855	+25%	+$2.66M	0.16%	133
2017 Q2	$10.1M	Buy	611,321 +128,695	+27%	+$1.79M	0.13%	149
2017 Q1	$6.66M	Buy	482,626 +169,992	+54%	+$2.73M	0.09%	172
2016 Q4	$5.93M	Buy	312,634 +89,158	+40%	+$1.71M	0.09%	166
2016 Q3	$4.96M	Buy	+223,476	New	+$4.2M	0.09%	172

ArrowMark Colorado Holdings's ENTL Position: Q1 2018 in Review

ArrowMark Colorado Holdings sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 986,137 shares — an estimated $24.1M sold.

ArrowMark Colorado Holdings first reported a position in ENTL in Q3 2016 and held it in 6 quarters. The position peaked at $24.1M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

ArrowMark Colorado Holdings reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
ArrowMark Colorado Holdings sold 986,137 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $24.1M.
ArrowMark Colorado Holdings first reported a position in Entellus Medical, Inc. Common Stock in Q3 2016 and held it in 6 quarters.
ArrowMark Colorado Holdings's Entellus Medical, Inc. Common Stock position peaked at $24.1M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2018, filed 15 May 2018.